AMPK activity showed a reduction in the orbital tissue of GO patients, and treatment of metformin, an AMPK activator, inhibited fibrosis and the expression of inflammatory molecules in OFs of GO via an AMPK/mTOR signaling pathway (Xu et al., 2022). This evidence concerns the gene MTOR and geroderma osteodysplastica.